miR-200 enhances mouse breast cancer cell colonization to form distant metastases

Derek M Dykxhoorn1, Yichao Wu, Huangming Xie

  • 1Department of Pediatrics, Immune Disease Institute, Harvard Medical School, Boston, Massachusetts, United States of America. ddykxhoorn@med.miami.edu

Plos One
|September 30, 2009
PubMed
Abstract

Insights

MicroRNAs (miRNAs) unexpectedly promote macroscopic metastasis in breast cancer. The miR-200 family enhances tumor colonization by promoting a mesenchymal to epithelial transition (MET), challenging the notion that epithelial traits hinder metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metastasis Research

Background:

  • Metastasis involves tumor cell dissociation, invasion, and colonization of distant sites, with the latter stage poorly understood.
  • Four isogenic mouse breast cancer cell lines (67NR, 168FARN, 4TO7, 4T1) model metastasis, with only 4T1 forming macroscopic lung and liver metastases.
  • Dysregulated microRNAs (miRNAs) are implicated in cancer progression and metastasis, prompting investigation into their role in differential metastatic capabilities.

Purpose of the Study:

  • To investigate whether altered miRNA expression explains the varying metastatic potential of isogenic mouse breast cancer cell lines.
  • To determine the specific role of miR-200 family miRNAs in the colonization and macroscopic metastasis of breast cancer cells.

Main Methods:

  • Analysis of miRNA expression using miRNA microarray and quantitative RT-PCR in four distinct mouse breast cancer cell lines.
  • Functional studies involving the overexpression of miR-200 in 4TO7 cells to assess its impact on metastatic capability.
  • Confirmation of miR-200's effect on epithelial characteristics by measuring E-cadherin and cytokeratin-18 expression.

Main Results:

  • 4T1 cells, which form macroscopic metastases, exhibited elevated expression of miR-200 family miRNAs compared to less metastatic cell lines.
  • Overexpression of miR-200 in 4TO7 cells significantly enhanced their ability to form lung and liver metastases.
  • miR-200 promoted a mesenchymal to epithelial transition (MET) by inhibiting Zeb2, leading to increased E-cadherin expression, consistent with acquired epithelial properties in highly metastatic cells.

Conclusions:

  • Contrary to previous findings, miR-200 expression unexpectedly enhances macroscopic metastasis in mouse breast cancer models.
  • Mesenchymal to epithelial transition (MET), induced by miR-200, may promote tumor colonization at distant metastatic sites.
  • The epithelial nature of a tumor does not reliably predict its metastatic outcome, highlighting a complex role for MET in cancer progression.